[1] KARLSSON J,DREIFALDT A C,MORDHORST L B, et al. Differences in outcome for cervical cancer patients treated with or without brachytherapy[J]. Brachytherapy, 2017, 16(1):133-140. [2] WANG W,HOU X,YAN J, et al. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women[J]. BMC Cancer, 2017, 17(1):510. [3] KWEKKEBOOM K L,DENDAAS N R,STRAUB M, et al. Patterns of pain and distress during high-dose-rate intracavity brachytherapy for cervical cancer[J]. J Support Oncol, 2009, 7(3):108-114. [4] WARNOCK C. Patients' experiences of intracavity brachytherapy treatment for gynaecological cancer[J]. Eur J Oncol Nurs, 2005, 9(1):44-55. [5] ROLLISON B,STRANG P. Pain, nausea and anxiety during intra-uterine brachytherapy of cervical carcinomas[J]. Support Care Cancer, 1995, 3(3):205-207. [6] WIEBE E,SURRY K,DERRAH L, et al. Pain and symptom assessment during multiple fractions of gynecologic high-dose-rate brachytherapy[J]. Brachytherapy, 2011,10(5):352-356. [7] BHANABHAI H,SAMANT R,E C, et al. Pain assessment during conscious sedation for cervical cancer high-dose-rate brachytherapy[J]. Curr Oncol, 2013, 20(4):e307-310. [8] CORN B W,HANLON A L,PAJAK T F, et al. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix[J]. Gynecol Oncol, 1994, 53(3):294-300. [9] WATANABE NEMOTO M,NOZAKI-TAGUCHI N,TOGASAKI G, et al. New approach to relieving pain and distress during high-dose-rate intracavitary irradiation for cervical cancer[J]. Brachytherapy, 2015, 14(5):642-647. [10] BANSAL R,KHAN JOAD A S,SAXENA M, et al. Oral midazolam is a safe and effective premedication in adult outpatients undergoing brachytherapy for cancer cervix under general anaesthesia:A prospective randomised, double blind placebo-controlled study[J]. Indian J Anaesth, 2015,59(7):437-439. [11] KAMER S,OZSARAN Z,CELIK O, et al. Evaluation of anxiety levels during intracavitary brachytherapy applications in women with gynecological malignancies[J]. Eur J Gynaecol Oncol, 2007, 28(2):121-124. [12] HILLER J G,ISMAIL H M,HOFMAN M S, et al. Neuraxial anesthesia reduces lymphatic flow:proof-of-concept in first in-human study[J]. Anesth Analg, 2016, 123(5):1325-1327. [13] SMITH M D, TODD J G,SYMONDS R P. Analgesia for pelvic brachytherapy[J]. Br J Anaesth, 2002, 88(2):270-276. [14] VISWANATHAN A N,CREUTZBERG C L,CRAIGHEAD P, et al. International brachytherapy practice patterns:a survey of the Gynecologic Cancer Intergroup (GCIG)[J]. Int J Radiat Oncol Biol Phys, 2012, 82(1):250-255. [15] JONES B,TAN L T,BLAKE P R, et al. Results of a questionnaire regarding the practice of radiotherapy for carcinoma of the cervix in the UK[J]. Br J Radiol, 1994, 67(804):1226-1230. [16] PETRIC P,HUDEJ R,HANUNA O, et al. MRI-assisted cervix cancer brachytherapy pre-planning, based on application in paracervical anaesthesia:final report[J]. Radiol Oncol, 2014, 48(3):293-300. [17] PROUD C. The use of oral transmucosal fentanyl citrate during high-dose-rate gynecologic brachytherapy[J]. Clin J Oncol Nurs, 2007, 11(4):561-567. [18] XU-WELLIVER M,LIN L L. Evaluation of a balloon-based vaginal packing system and patient-controlled analgesia for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy[J]. Pract Radiat Oncol, 2013, 3(4):263-268. [19] LEONG Y H,TAN K H S,AI CHOO B, et al. Novel anesthetic technique for combined intracavitary and interstitial brachytherapy for cervix cancer in an outpatient setting[J]. J Contemp Brachytherapy, 2017, 9(3):236-241. [20] TAN P W, KOH V Y, TANG J L. Outpatient combined intracavitary and interstitial cervical brachytherapy:barriers and solutions to implementation of a successful programme-a single institutional experience[J]. J Contemp Brachytherapy, 2015, 7(3):259-263. [21] TANGSIRIWATTHANA T,SANGKOMKAMHANG U S,LUMBIGANON P, et al. Paracervical local anaesthesia for cervical dilatation and uterine intervention[J]. Cochrane Database Syst Rev, 2009(1):CD005056. [22] ANBUMANI S,ANCHINEYAN P,NARAYANASAMY A, et al. Treatment planning methods in high dose rate interstitial brachytherapy of carcinoma cervix:a dosimetric and radiobiological analysis[J]. ISRN Oncol, 2014, 2014:125020. [23] TSUJINO K. The impact of general anesthesia usage during hdr intracavitary brachytherapy for cervical cancer on the quality of applicationsujino 2011[J]. Hyogo Cancer Center, 2011(2):S453-S454. [24] LIM K H,LU J J,WYNNE C J, et al. A study of complications arising from different methods of anesthesia used in high-dose-rate brachytherapy for cervical cancer[J]. Am J Clin Oncol, 2004, 27(5):449-451. [25] SHARMA D N,CHAUDHARI P,SHARMA S, et al. Comparison of high-dose-rate intracavitary brachytherapy dosimetry with and without anesthesia in patients with cervical carcinoma[J]. J Appl Clin Med Phys, 2014, 15(2):4670. [26] JANAKI M G,NIRMALA S,KADAM A R, et al. Epidural analgesia during brachytherapy for cervical cancer patients[J]. J Cancer Res Ther, 2008, 4(2):60-63. [27] VISWANATHAN A N,THOMADSEN B. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I:general principles[J]. Brachytherapy, 2012, 11(1):33-46. [28] ROESSLER B,SIX L M,GUSTORFF B. Anaesthesia for brachytherapy[J]. Curr Opin Anaesthesiol, 2008, 21(4):514-518. [29] BENRATH J,KOZEK-LANGENECKER S,HVPFL M, et al. Anaesthesia for brachytherapy-51/2 yr of experience in 1622 procedures[J]. Br J Anaesth, 2006, 96(2):195-200. [30] WOJCIESZEK E,REMBIELAK A,BIALAS B, et al. Anaesthesia for radiation therapy-Gliwice experience[J]. Neoplasma, 2010, 57(2):155-160. [31] WEITMANN H D,GUSTORFF B,VAUPEL P, et al. Oxygenation status of cervical carcinomas before and during spinal anesthesia for application of brachytherapy[J]. Strahlenther Onkol, 2003, 179(9):633-640. [32] KIRCHHEINER K,CZAJKA-PEPL A,PONOCNY-SELIGER E, et al. Posttraumatic stress disorder after high-dose-rate brachytherapy for cervical cancer with 2 fractions in 1 application under spinal/epidural anesthesia:incidence and risk factors[J]. Int J Radiat Oncol Biol Phys, 2014, 89(2):260-267. [33] JAIN R,MISHRA S, BHATNAGARS. Comparison of different anaesthetic techniques for high-dose-rate intracavitory radiotherapy for carcinoma cervix[J]. Int J Anesthesiol, 2008,17(1):8. [34] MICHALEK-SAUBERER A, KOZEK-LANGENECKER S A,HEINZL H, et al. Median effective local anesthetic doses of plain bupivacaine and ropivacaine for spinal anesthesia administered via a spinal catheter for brachytherapy of the lower abdomen[J]. Reg Anesth Pain Med, 2008, 33(1):4-9. [35] AMSBAUGH A K,AMSBAUGH M J,EL-GHAMRYM N, et al. Optimal epidural analgesia for patients diagnosed as having gynecologic cancer undergoing interstitial brachytherapy[J]. J Clin Anesth, 2016, 35:509-515. [36] NIELSEN A A,LIYANAGE T A,LEISEROWITZ G S, et al. Optimal perioperative anesthesia management for gynecologic interstitial brachytherapy[J]. J Contemp Brachytherapy, 2017, 9(3):216-223. [37] DAWKINS C J. An analysis of the complications of extradural and caudal block[J]. Anaesthesia, 1969, 24(4):554-563. [38] NAG S, ERICKSON B,THOMADSEN B, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix[J]. Int J Radiat Oncol Biol Phys, 2000, 48(1):201-211. [39] CHEN H C, LEUNG S W,WANG C J, et al. Local vaginal anesthesia during high-dose-rate intracavitary brachytherapy for cervical cancer[J]. Int J Radiat Oncol Biol Phys, 1998, 42(3):541-544. [40] COUTAUX A,SALOMON L,ROSENHEIM M, et al. Care related pain in hospitalized patients:a cross-sectional study[J]. Eur J Pain, 2008, 12(1):3-8. [41] MENDEZ L C,CHOI S,D'ALIMONTE L, et al. Opioid consumption and pain in gynecological cancer patients treated with interstitial brachytherapy[J]. Brachytherapy, 2017, 16(4):870-876. |